Investment Rating - The investment rating for the company is "Buy" and is maintained [10]. Core Views - The company achieved total revenue of 2.189 billion and net profit attributable to shareholders of 133 million in H1 2025, representing a year-on-year increase of 7% and 5% respectively. However, Q2 2025 saw a decline in revenue and net profit by 1% and 10% respectively [2][6]. - The company is expanding its overseas market presence while simultaneously enhancing its domestic brand operations. It is focusing on non-US markets and developing products tailored to local styles in Europe and Asia [8]. - The company is expected to achieve a net profit of 330 million in 2025, with a proposed dividend of 0.16 yuan per share, corresponding to a dividend payout ratio of 40% [8]. Revenue Analysis - In H1 2025, domestic sales reached 541 million, growing by 15%, while overseas sales were 1.642 billion, increasing by 4%. The overall revenue composition was 25% domestic and 75% overseas [8]. - The revenue from office chairs, sofas, and massage chairs in H1 2025 was 2.147 billion, 466 million, and 98 million respectively, with year-on-year growth rates of 9%, 36%, and a decline of 3% [8]. Profitability Analysis - The gross margin decreased by 1.0 percentage points year-on-year in H1 2025, with specific declines in office chairs, sofas, and massage chairs of 1.1, 4.5, and 3.9 percentage points respectively. However, the gross margin for domestic sales improved significantly due to an increase in mid-to-high-end product sales [8]. - The gross margin for Q2 2025 was 22.8%, reflecting a year-on-year decrease of 0.6 percentage points [8].